Israel VC Yozma Group sets up biotech-focused JV with S Korea’s Mirae SCI

Israel-based venture capital firm Yozma Group has invested 5 billion won ($4.65 million) in Korea’s photoconductor drums producer Mirae SCI through convertible bonds to set up a biotechnology-focused joint venture, The Investors reported.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at